Immune function surveillance: Association with rejection, infection and cardiac allograft vasculopathy

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 376-382

  Heikal, N M ^a,b   Bader, F M ^b   Martins, T B ^a   Pavlov, I Y ^a   Wilson, A R ^a   Barakat, M ^b   Stehlik, J ^b   Kfoury, A G ^b   Gilbert, E M ^b   Delgado, J C ^a,b   Hill, H R ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CD30 ANTIGEN; INTERLEUKIN 5; INTERLEUKIN 8; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIBODY MEDIATED REJECTION; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FUNGUS CULTURE; GRAFT INFECTION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIREMIA;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ANTIGENS, CD30; BIOPSY; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSION; INTERLEUKIN-5; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84873317972     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.04.034     Document Type: Article

References (31)

1. L.A. DeBruyne, R.D. Ensley, S.L. Olsen Increased frequency of alloantigen-reactive helper T lymphocytes is associated with human cardiac allograft rejection Transplantation 56 1993 722
2. V.B. Sampson, S.P. Dunn, B. Rymeski Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients J Pediatr Surg 43 2008 1134
3. J.A. Kobashigawa, K.K. Kiyosaki, J.K. Patel Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes J Heart Lung Transplant 29 2010 504
4. S. Gupta, J.D. Mitchell, D.W. Markham Utility of the Cylex assay in cardiac transplant recipients J Heart Lung Transplant 27 2008 817
5. G. Schlaf, W.W. Altermann, A. Rothhoff Soluble CD30 serum level - an adequate marker for allograft rejection of solid organs? Histol Histopathol 22 2007 1269
6. A. Nikaein, C. Spiridon, J. Hunt Pre-transplant level of soluble CD30 is associated with infection after heart transplantation Clin Transplant 21 2007 744
7. E. Ypsilantis, T. Key, J.A. Bradley Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome J Heart Lung Transplant 28 2009 1206
8. R.J. Kowalski, D.R. Post, R.B. Mannon Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay Transplantation 82 2006 663
9. T.B. Martins, B.M. Pasi, C.M. Litwin Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum Clin Diagn Lab Immunol 11 2004 325
10. I. Pavlov, T.B. Martins, J.C. Delgado Development and validation of fluorescent microsphere immunoassay for soluble CD30 testing Clin and Vaccine Immunol 16 2009 1327
11. S. Stewart, G.L. Winters, M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710
12. M. Fishbein, J. Kogashigawa Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy Curr Opin Cardiol 19 2004 166
13. M.R. Mehra, M.G. Crespo-Leiro, A. Dipchand International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy J Heart Lung Transplant 29 2010 717
14. N.L. Thai, D. Blisard, K. Tom Pancreas transplantation under alemtuzumab (Campth-1H) and tacrolimus: correlation between low T-cell responses and infection Transplantation 82 2006 1649
15. J.W. Rossano, S.W. Denfield, J.J. Kim Assessment of the Cylex ImmuKnow Cell Function Assay in pediatric heart transplant patients J Heart Lung Transplant 28 2009 26
16. D.Q. Truong, A.A. Darwish, J. Gras Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement Transpl Immunol 17 2007 283
17. C. Spiridon, J. Hunt, M. Mack Evaluation of soluble CD30 as an immunologic marker in heart transplant recipients Transplant Proc 38 2006 3689
18. F. Monsalve, A.T. Romero, J. Estevez Serum level of soluble CD30 molecule in hepatitis B virus infection Rev Med Chil 129 2001 1248
19. R. Weimera, C.S. Usalb, S. Yildiza Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens Am J Transplant 6 2006 1865
20. G. Pizzolo, F. Vinante, G. Nadali High serum level of sCD30 in acute primary HIV-1 infection Clin Exp Immunol 108 1997 251
21. H.P. Hansen, S. Dietrich, T. Kisseleva CD30 shedding from karpas 299 lymphoma cells is mediated by TNF-a-converting enzyme J Immunol 165 2000 6703
22. S. Pelz, G. Opelz, M. Wiesel Soluble Cd30 as a predictor of kidney graft outcome Transplantation 73 2002 3
23. E. Frisaldi, R. Conca, P. Magistroni Prognostic values of soluble CD30 and CD30 gene polymorphism in heart transplantation Transplantation 81 2006 1153
24. L. Tan, W.M. Howell, J.L. Smith Sequential monitoring of peripheral T-lymphocyte cytokine gene expression in the early post renal allograft period Transplantation 71 2001 751
25. D.S. Nath, H.I. Basha, V. Tiriveedhi Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy J Heart Lung Transplant 29 2010 1277
26. T.B. Martins, J.L. Anderson, J.B. Muhlestein Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay Am J Clin Pathol 125 2006 906
27. T.B. Martins, N.H. Augustine, H.R. Hill Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci J Immunol Methods 316 2006 97
28. R.F. Wilson, A.L. McGinn, T.H. Johnson Sympathetic reinnervation after heart transplantation in human beings J Heart Lung Transplant 11 Suppl 3, Pt 2 1992 S88
29. I. Kaczmarek, M.A. Deutsch, T. Kauke Donor-specific HLA alloantibodies: long term impact on cardiac allograft vasculopathy and mortality after heart transplant Exp Clin Transplant 6 2008 229
30. L. Gullestad, S. Simonsen, T. Ueland Possible role of proinflammatory cytokines in heart allograft coronary artery disease Am J Cardiol 84 1999 999
31. L. Ternstrom, A. Jeppsson, A. Ricksten Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy J Heart Lung Transplant 24 2005 433